Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Glendenning

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Clinical Biochemist. Reviews|November 10, 2005
Standardised, metabolite-specific assays with validated decision limits: utopian ideal or achievable goal?Paul Glendenning
The Clinical Biochemist. Reviews|April 1, 2011
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards: osteoporos int 2011;22:391-420Paul Glendenning
Australian Prescriber|December 10, 2015
Measuring vitamin DPaul Glendenning
Annals of Clinical Biochemistry|April 24, 2013
It is time to start ordering ionized calcium more frequently: preanalytical factors can be controlled and postanalytical data justify measurementPaul Glendenning
The Clinical Biochemist. Reviews|September 13, 2008
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice GuidelinePaul Glendenning
The American Journal of Clinical Nutrition|January 24, 2003
Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin DPaul Glendenning
The Medical Journal of Australia|May 10, 2002
Vitamin D deficiency and multicultural AustraliaPaul Glendenning
The Medical Journal of Australia|April 3, 2004
8: Disorders of bone and mineral other than osteoporosisRichard L Prince, Paul Glendenning
Critical Reviews in Clinical Laboratory Sciences|September 18, 2015
Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementationPaul Glendenning, Charles A Inderjeeth
The Medical Journal of Australia|August 16, 2005
Fit for a fractureHannah M Seymour, Paul Glendenning
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Clinical Biochemist. Reviews|November 10, 2005
Standardised, metabolite-specific assays with validated decision limits: utopian ideal or achievable goal?Paul Glendenning
The Clinical Biochemist. Reviews|April 1, 2011
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards: osteoporos int 2011;22:391-420Paul Glendenning
Australian Prescriber|December 10, 2015
Measuring vitamin DPaul Glendenning
Annals of Clinical Biochemistry|April 24, 2013
It is time to start ordering ionized calcium more frequently: preanalytical factors can be controlled and postanalytical data justify measurementPaul Glendenning
The Clinical Biochemist. Reviews|September 13, 2008
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice GuidelinePaul Glendenning
The American Journal of Clinical Nutrition|January 24, 2003
Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin DPaul Glendenning
The Medical Journal of Australia|May 10, 2002
Vitamin D deficiency and multicultural AustraliaPaul Glendenning
The Medical Journal of Australia|April 3, 2004
8: Disorders of bone and mineral other than osteoporosisRichard L Prince, Paul Glendenning
Critical Reviews in Clinical Laboratory Sciences|September 18, 2015
Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementationPaul Glendenning, Charles A Inderjeeth
The Medical Journal of Australia|August 16, 2005
Fit for a fractureHannah M Seymour, Paul Glendenning
Pageof 5